Gilead Sciences, Inc. (ETR:GIS)
Germany
· Delayed Price · Currency is EUR 104.26
+1.28 (1.24%)
Feb 20, 2025, 5:35 PM CET
Gilead Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 28,754 | 27,116 | 27,281 | 27,305 | 24,689 | Upgrade
|
| Revenue Growth (YoY) | 6.04% | -0.60% | -0.09% | 10.60% | 9.98% | Upgrade
|
| Cost of Revenue | 6,251 | 6,019 | 5,657 | 5,526 | 3,691 | Upgrade
|
| Gross Profit | 22,503 | 21,097 | 21,624 | 21,779 | 20,998 | Upgrade
|
| Selling, General & Admin | 5,903 | 5,537 | 5,673 | 5,246 | 5,112 | Upgrade
|
| Research & Development | 5,731 | 5,758 | 4,998 | 4,601 | 4,927 | Upgrade
|
| Operating Expenses | 11,634 | 11,295 | 10,671 | 9,847 | 10,039 | Upgrade
|
| Operating Income | 10,869 | 9,802 | 10,953 | 11,932 | 10,959 | Upgrade
|
| Interest Expense | -977 | -944 | -935 | -1,001 | -984 | Upgrade
|
| Interest & Investment Income | - | 376 | 376 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -21 | -21 | -23 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 280 | 11 | -279 | -6 | 244 | Upgrade
|
| EBT Excluding Unusual Items | 10,172 | 9,224 | 10,094 | 10,902 | 10,219 | Upgrade
|
| Merger & Restructuring Charges | -189 | -527 | - | - | -920 | Upgrade
|
| Gain (Loss) on Sale of Investments | -274 | -167 | -657 | -610 | -1,662 | Upgrade
|
| Legal Settlements | - | -525 | - | -1,075 | - | Upgrade
|
| Other Unusual Items | -175 | 60 | 21 | - | - | Upgrade
|
| Pretax Income | 691 | 6,860 | 5,814 | 8,278 | 1,669 | Upgrade
|
| Income Tax Expense | 211 | 1,247 | 1,248 | 2,077 | 1,580 | Upgrade
|
| Earnings From Continuing Operations | 480 | 5,613 | 4,566 | 6,201 | 89 | Upgrade
|
| Minority Interest in Earnings | - | 52 | 26 | 24 | 34 | Upgrade
|
| Net Income | 480 | 5,665 | 4,592 | 6,225 | 123 | Upgrade
|
| Net Income to Common | 480 | 5,665 | 4,592 | 6,225 | 123 | Upgrade
|
| Net Income Growth | -91.53% | 23.37% | -26.23% | 4960.98% | -97.72% | Upgrade
|
| Shares Outstanding (Basic) | 1,247 | 1,248 | 1,255 | 1,256 | 1,257 | Upgrade
|
| Shares Outstanding (Diluted) | 1,255 | 1,258 | 1,262 | 1,262 | 1,263 | Upgrade
|
| Shares Change (YoY) | -0.24% | -0.32% | - | -0.08% | -1.10% | Upgrade
|
| EPS (Basic) | 0.38 | 4.54 | 3.66 | 4.96 | 0.10 | Upgrade
|
| EPS (Diluted) | 0.38 | 4.50 | 3.64 | 4.93 | 0.10 | Upgrade
|
| EPS Growth | -91.56% | 23.63% | -26.17% | 4938.22% | -97.68% | Upgrade
|
| Free Cash Flow | 10,305 | 7,421 | 8,344 | 10,805 | 7,518 | Upgrade
|
| Free Cash Flow Per Share | 8.21 | 5.90 | 6.61 | 8.56 | 5.95 | Upgrade
|
| Dividend Per Share | 3.080 | 3.000 | 2.920 | 2.840 | 2.720 | Upgrade
|
| Dividend Growth | 2.67% | 2.74% | 2.82% | 4.41% | 7.94% | Upgrade
|
| Gross Margin | 78.26% | 77.80% | 79.26% | 79.76% | 85.05% | Upgrade
|
| Operating Margin | 37.80% | 36.15% | 40.15% | 43.70% | 44.39% | Upgrade
|
| Profit Margin | 1.67% | 20.89% | 16.83% | 22.80% | 0.50% | Upgrade
|
| Free Cash Flow Margin | 35.84% | 27.37% | 30.59% | 39.57% | 30.45% | Upgrade
|
| EBITDA | 13,634 | 12,495 | 13,056 | 13,982 | 12,439 | Upgrade
|
| EBITDA Margin | 47.42% | 46.08% | 47.86% | 51.21% | 50.38% | Upgrade
|
| D&A For EBITDA | 2,765 | 2,693 | 2,103 | 2,050 | 1,480 | Upgrade
|
| EBIT | 10,869 | 9,802 | 10,953 | 11,932 | 10,959 | Upgrade
|
| EBIT Margin | 37.80% | 36.15% | 40.15% | 43.70% | 44.39% | Upgrade
|
| Effective Tax Rate | 30.54% | 18.18% | 21.47% | 25.09% | 94.67% | Upgrade
|
| Revenue as Reported | 28,754 | 27,116 | 27,281 | 27,305 | 24,689 | Upgrade
|
| Advertising Expenses | - | 826 | 778 | 735 | 795 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.